On Thursday June 4, 2015, the panel of advisers to the U.S. Food and Drug Administration voted 18 to 6 to recommend that the agency approve flibanserin— nicknamed ‘women’s Viagra’ — as the first prescription treatment to boost libido in women. The contingency? That the drug’s manufacturer...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.